Enrolling by invitationPHASE1, PHASE2NCT06369571
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Studying Metabolic diseases with epilepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Tanya J McDonald, MD, PhDJohns Hopkins University
- Intervention
- Atorvastatin 10mg(drug)
- Enrollment
- 22 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- Johns Hopkins Hospital, Baltimore, Maryland, United States
Collaborators
American Heart Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06369571 on ClinicalTrials.govOther trials for Metabolic diseases with epilepsy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07096414Effect of Vitamin D3 Supplementation on Brain Waves in Male Epileptic Patients With Hypovitaminosis DBangladesh Medical University
- RECRUITINGNANCT07085598Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis DBangladesh Medical University
- ACTIVE NOT RECRUITINGNCT02694094Impact of Ketogenic Diets on Cardiovascular Health in Adults With EpilepsyJohns Hopkins University